OPEN as of November 1, 2026. The Foundation's October 7, 2026 announcement confirms applications opened October 1, 2026 and close January 22, 2027. One-year awards expected to start July 1, 2027.
National — Charlie Landers Foundation 2027 Ewing Sarcoma Research Grants ($20,000–$150,000; January 22, 2027)
2027 pediatric Ewing sarcoma research grants of $20,000–$150,000 for one year, administered through U.S. nonprofit institutions. MD/PhD investigators may apply by January 22, 2027. Preclinical, translational and clinical research; no indirect costs; optional second year subject to approval.
Funding$20,000–$150,000 per individual applicant grant for one year; possible second year of $20,000–$150,000 subject to documented progress and separate approval. Overall pool not published. Indirect costs prohibited.
DeadlineJanuary 22, 2027. No closing hour or time zone published by the Foundation. Applications opened October 1, 2026; award announcement expected March 24, 2027.
Last verified2026-11-01
Required next actionReview complete 2027 application instructions at https://www.thecharlielandersfoundation.org/2027-grant-application, compile cover page, NIH biosketches, lay/scientific abstract, four-page research plan, one-page budget and justification, other funding disclosure and collaborator letters into one PDF, and submit via that page's application form by January 22, 2027. Confirm the precise submission cutoff with the funder.
Broad Eligibility
New or established investigators holding MD, PhD or MD/PhD conducting pediatric Ewing sarcoma research. Researchers need not be U.S. citizens, but recipient must be a nonprofit institution or organization operating in the United States. Proposed funding cannot duplicate active sponsored studies.
Atlas Analysis
Official-source verification November 1, 2026: controlling 2027 application https://www.thecharlielandersfoundation.org/2027-grant-application and Foundation announcement dated October 7, 2026 https://www.thecharlielandersfoundation.org/post/2027-grant-applications. Direct applicant award $20,000–$150,000 for one year; no total program pool specified. Application deadline January 22, 2027 without published time or time zone. MD/PhD investigator qualification, U.S. nonprofit recipient, nonduplicative research, eligible salary/fringe/travel/supplies/equipment under $10,000, no indirect costs, required interim/final reports, submission as single PDF and complete proposal sections confirmed from official application. No matching percentage or reimbursement condition specified. Second-year funding is conditional and not guaranteed. Actual applicant-facing research financial assistance rather than government procurement.
2027 Ewing Sarcoma Research Grant
The Charlie Landers Foundation is accepting applications for its 2027 competitive research grant supporting innovative preclinical, translational and clinical studies of pediatric Ewing sarcoma. The award funds research through a nonprofit U.S. institution or organization and is not a procurement contract.
Applicant award and deadline
Individual award: $20,000–$150,000 for one year. The application deadline is January 22, 2027. The Foundation has not published a closing hour or time zone. Decisions are scheduled for March 24, 2027, with the award period starting July 1, 2027. A second year of $20,000–$150,000 may be considered based on satisfactory progress and further board and medical review; renewal is not guaranteed. An overall program funding pool is not specified.
Eligible investigators and institutions
New and established investigators with an MD, PhD, or combined MD/PhD may apply. Researchers need not be U.S. citizens, but funds must be awarded to nonprofit institutions or organizations operating in the United States. Proposed work must be distinct from, and must not duplicate, existing sponsored research. Extensions of current studies may be considered only where the requested activities and funding do not overlap.
Allowable costs and restrictions
Allowable project budgets can include salaries, fringe benefits, research travel, supplies and small equipment costing less than $10,000. Indirect costs are not permitted. The Foundation does not state a matching-funds requirement or a general reimbursement/payment schedule in its published instructions. Awardees must provide an interim progress report about six months after the start and a final report about one month after project completion.
Application instructions
Submit one combined PDF proposal using the application form on the Foundation’s official grant page. Include a one-page cover page naming the project and institution; NIH-format biosketches for principal investigators and participating trainees; a one-page lay and scientific abstract; a four-page research plan with specific aims, significance, approach, timeline and references; a one-page budget and justification; other active or pending support; and relevant collaborator letters. A budget template is linked from the official instructions. Confirm any funder amendments before submission.
Official 2027 application and complete guidance: The Charlie Landers Foundation 2027 Research Grant. Cycle announcement: October 7, 2026 funding announcement.
Source verificationReferenced source · www.thecharlielandersfoundation.orgAtlas last verified this record 2026-11-01. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
